Top Abstract Purchase Related
Home
>
Node
>
Subnode

The prophylactic and therapeutic use of piracetam in reproduced myocardial infarct

Kresiun, V.I.; Kravchenko, L.S.; Kadyrova, L.L.

Farmakologiia i Toksikologiia 53(2): 29-31

1990

ISSN/ISBN: 0014-8318
PMID: 2369949
Document Number: 357782
The effect of piracetam on the dynamics of the infarction development, free radical lipid peroxidation in the myocardium and the immunological reactivity was studied on dogs with experimental myocardial infarction during the course and prophylactic treatment. The antiarrhythmic, antihypoxic, antioxidant effects of the drug, its positive influence on the parameters of humoral and cellular immunity were revealed. The comparative assessment of piracetam action during cardiogenic stress caused by myocardial infarction showed a higher pharmacological effect in therapeutic use.

Document emailed within 1 workday
Secure & encrypted payments

Kudrin, A.N.; Kogan, A.K.; Korolev, V.V.; Nikolaev, S.M.; Beskrovnova, N.N. 1978: Free-radical lipid oxidation in the pathogenesis of myocardial infarct and the therapeutic and prophylactic role of antioxidants, sodium selenite and its combination with vitamin e Kardiologiia 18(2): 115-118
Spiecker, M.; Erbel, R.; Janssen, H.; Meyer, J. 1994: Significance of coronary perfusion for therapeutic success in myocardial infarct Herz 19(6): 353-359
Stiefelhagen, P. 2000: Thrombosis ABC, 20: Myocardial infarct. Vessel reopening is the primary therapeutic goal MMW Fortschritte der Medizin 142(40): 40
Gadzhieva, F.U.; Sobolev, A.V.; Dorofeeva, Z.Z.; Sergakova, L.M.; D'iakonova, E.G. 1986: Integral indices of the automatically reproduced spatial QRS loop in the diagnosis of different forms of myocardial hypertrophy Kardiologiia 26(11): 18-23
Gol'dberg, G.A.; Chavdar, F.N.; Suriadnova, B.A.; Tatarchenko, I.P.; Rabinovich, B.I. 1980: Therapeutic use of nitroglycerin in pulmonary edema and cardiac asthma in myocardial infarct patients Kardiologiia 20(4): 21-25
Noll, G.; Kaufmann, U.; Wenzel, R.R.; Lüscher, T.F. 1996: Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs Schweizerische Medizinische Wochenschrift 126(5): 164-176
Motte, G.; Gourgon, R.; Lorente, P.; Waynberger, M.; Bouvrain 1971: Hemodynamic investigation in the acute phase of myocardial infarct. II. Results. Therapeutic and prognostic importance Archives des Maladies du Coeur et des Vaisseaux 64(2): 217-230
Kalinkin, L.A.; Chumakova, V.P.; Bespalova, V.G.; Bogovskaia, V.D.; Panchenko, S.N. 1982: Lymphocyte dehydrogenase activity of the blood in myocardial infarct during rehabilitation using therapeutic physical exercise Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 24-26
Goldman, L. 1980: Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data Recenti Progressi in Medicina 68(4): 382-393
Wasilewska, J. 1978: Modern views on the pathogenesis and physiopathology of cardiogenic shock in acute myocardial infarct--indications for therapeutic management Kardiologia Polska 21(2): 145-150
Naegeli, B.; Bertel, O.; Urban, P.; Angehrn, W.; Siegrist, P.; Stauffer, J.C.; Baumann, P.C.; Jolliet, P.; Simeon-Dubach, D.; Meier, B.; Wunderlin, R. 1998: Acute myocardial infarct in Switzerland: results from the PIMICS Heart Infarct Register. PIMICS Project (Prospective Ischemia Myocardial Infarction Captopril Survey) Schweizerische Medizinische Wochenschrift 128(19): 729-736
Jouve, R.; Puddu, P.E.; Torresani, J.; Reale, A.; Jouve, A. 1983: Duration of electric systole in the acute phase of myocardial infarct. Methodology, natural history, semiological value, therapeutic consequences Annales de Cardiologie et d'Angeiologie 32(3): 149-155
1994: ACE inhibitors in cardiac insufficiency and myocardial infarct. What happens after myocardial infarct? Zeitschrift für Kardiologie 83(11 Suppl): 1-4
Kleinau, H.; Wilhelm, R. 1981: Prophylactic and therapeutic intermittent positive pressure breathing with combined therapeutic aerosols (IPPB/I)--functional and morphological effects. II. Therapeutic IPPB/I in ventilation disturbances of the lung Zeitschrift für Erkrankungen der Atmungsorgane 156(2): 151-158
Tillmanns, H.; Knapp, W.H.; Mehmel, H.C.; Kübler, W.; Doll, J.; von Olshausen, K.; Schömig, A. 1977: Regional myocardial perfusion and myocardial function in myocardial infarct with normal coronary angiogram Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 249-252
López Martínez, R. 1988: Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo Acta Otorrinolaringologica Espanola 39(4): 287-288
Bluzhas, I.N.; Stalioraĭtite, E.I.; Grazhuliavichene, R.I. 1982: Acute myocardial infarct register: the intravital and morphological criteria of "definite" and "possible" infarct Kardiologiia 22(1): 82-85
Di Cantogno, L.V.; Vizzeri, E.; Orione, G. 1971: Modes of onset and characteristics of the infarct crisis in 500 cases of myocardial infarct. II. Clinical symptomatology Minerva Medica 62(31): 1618-1624
Riabykina, G.V.; Dorofeeva, Z.Z. 1977: Evaluation of the condition of the peri-infarct zone in acute myocardial infarct according to 35 precordial leads Kardiologiia 17(8): 89-96
Maslov, A.G.; Smirnov, V.P. 1993: The effect of transcardiac galvanization on the function of the microcirculatory bed of the peri-infarct area in experimental myocardial infarct Biulleten' Eksperimental'noi Biologii i Meditsiny 116(7): 85-86